NORDIC BIOTECH GENERAL PARTNER ApS: Financial statements 2012
CVR: 26270367
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
NORDIC BIOTECH GENERAL PARTNER ApS (CVR 26270367) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 20,526 and a net result of DKK 15,398. Equity in the 2012 report amounted to DKK 225,533. The solvency ratio was 93.3%.
- Gross Profit
- DKK 20,526
- Profit/Loss
- DKK 15,398
- Equity
- DKK 225,533
- Total Assets
- DKK 241,758
Official annual report
Keep an eye on NORDIC BIOTECH GENERAL PARTNER ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of January 9, 2012, Christian Karsten Hansen has stepped down as director of NORDIC BIOTECH GENERAL PARTNER ApS.
About NORDIC BIOTECH GENERAL PARTNER ApS
NORDIC BIOTECH GENERAL PARTNER ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company is owned by TECH GROWTH INVEST ApS and C. HANSEN INVEST ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 163,699 and a net result of DKK 178,169 compared with DKK 67,346 the year before. Equity in the 2025 report amounted to DKK 1,214,065.